Feasibility of continuous glucose monitoring in patients with type 1 diabetes at two district hospitals in Neno, Malawi: a randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 May 2024
Historique:
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 8 5 2024
Statut: epublish

Résumé

To assess the feasibility and change in clinical outcomes associated with continuous glucose monitoring (CGM) use among a rural population in Malawi living with type 1 diabetes. A 2:1 open randomised controlled feasibility trial. Two Partners In Health-supported Ministry of Health-run first-level district hospitals in Neno, Malawi. 45 people living with type 1 diabetes (PLWT1D). Participants were randomly assigned to Dexcom G6 CGM (n=30) use or usual care (UC) (n=15) consisting of Safe-Accu glucose monitors and strips. Both arms received diabetes education. Primary outcomes included fidelity, appropriateness and severe adverse events. Secondary outcomes included change in haemoglobin A1c (HbA1c), acceptability, time in range (CGM arm only) SD of HbA1c and quality of life. Participants tolerated CGM well but were unable to change their own sensors which resulted in increased clinic visits in the CGM arm. Despite the hot climate, skin rashes were uncommon but cut-out tape overpatches were needed to secure the sensors in place. Participants in the CGM arm had greater numbers of dose adjustments and lifestyle change suggestions than those in the UC arm. Participants in the CGM arm wore their CGM on average 63.8% of the time. Participants in the UC arm brought logbooks to clinic 75% of the time. There were three hospitalisations all in the CGM arm, but none were related to the intervention. This is the first randomised controlled trial conducted on CGM in a rural region of a low-income country. CGM was feasible and appropriate among PLWT1D and providers, but inability of participants to change their own sensors is a challenge. PACTR202102832069874.

Identifiants

pubmed: 38719319
pii: bmjopen-2023-075554
doi: 10.1136/bmjopen-2023-075554
doi:

Substances chimiques

Glycated Hemoglobin 0
Blood Glucose 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e075554

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Apoorva Gomber (A)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Francis Valeta (F)

Partners In Health, Neno, Malawi.

Matthew M Coates (MM)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Celina Trujillo (C)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Partners In Health, Boston, Massachusetts, USA.

Gina Ferrari (G)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Partners In Health, Boston, Massachusetts, USA.

Medson Boti (M)

Partners In Health, Neno, Malawi.

Kenwood Kumwenda (K)

Partners In Health, Neno, Malawi.

Bright Mailosi (B)

Partners In Health, Neno, Malawi.

Dester Nakotwa (D)

Partners In Health, Neno, Malawi.

Laura Drown (L)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Emily B Wroe (EB)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Partners In Health, Boston, Massachusetts, USA.
Program in Global Noncommunicable Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Ada Thapa (A)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Victor Mithi (V)

Partners In Health, Neno, Malawi.

Beatrice Matanje (B)

Partners In Health, Neno, Malawi.

Amos Msekandiana (A)

Kamuzu Central Hospital, Lilongwe, Malawi.

Paul H Park (PH)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Chiyembekezo Kachimanga (C)

Partners In Health, Neno, Malawi.

Gene Bukhman (G)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Partners In Health, Boston, Massachusetts, USA.
Program in Global Noncommunicable Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Todd Ruderman (T)

Partners In Health, Neno, Malawi.

Alma J Adler (AJ)

Center for Integration Science, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA aadler2@bwh.harvard.edu.
Program in Global Noncommunicable Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH